MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 6 Hold Rating(s), 13 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $194.53 (73.85% upside)

Analysts' Ratings History for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetActions
6/26/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Citigroup Inc.UpgradeNeutral -> Buy$154.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Robert W. BairdReiterated RatingNeutral$145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016BarclaysLower Price TargetEqual Weight$180.00 -> $165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Credit SuisseReiterated RatingHold$195.00 -> $186.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Bank of AmericaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016OppenheimerReiterated RatingBuy$228.00 -> $221.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016BMO Capital MarketsReiterated RatingBuy$168.00 -> $160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Morgan StanleyReiterated RatingOverweight$203.00 -> $189.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016Jefferies GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Goldman SachsLower Price Target$186.00 -> $168.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Stifel NicolausLower Price TargetBuy$245.00 -> $230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016JPMorgan Chase & Co.Lower Price Target$225.00 -> $185.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016SunTrustInitiated CoverageBuy$225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015Raymond JamesReiterated RatingStrong-Buy$225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Deutsche BankReiterated RatingBuy$215.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015Sanford C. BernsteinSet Price TargetBuy$267.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015NomuraUpgradeNeutral -> Buy$222.00 -> $246.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Alexion Pharmaceuticals (NASDAQ:ALXN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/28/2016Q116$1.13$1.11$710.98 million$701.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q415$1.10$1.13$703.42 million$701.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$1.01$1.16$668.33 million$666.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$1.39$1.44$628.03 million$636.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$1.32$1.28$594.40 million$600.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$1.28$1.30$589.85 million$599.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314$1.16$1.27$541.93 million$555.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214$1.07$1.12$509.54 million$512.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q114$1.26$1.53$560.22 million$566.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q413$0.83$0.87$430.08 million$441.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313$0.79$0.83$395.10 million$400.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013$0.68$0.73$364.80 million$370.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013$0.61$0.65$336.56 million$338.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012$0.52$0.60$316.49 million$320.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.47$0.60ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$0.36$0.47ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2012$0.38$0.45ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012$0.33$0.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2011$0.28$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011$0.26$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2011$0.51$0.59ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011$0.50$0.51ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Alexion Pharmaceuticals (NASDAQ:ALXN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.91$0.91$0.91
Q2 20161$1.07$1.07$1.07
Q3 20161$1.17$1.17$1.17
Q4 20161$1.28$1.28$1.28
(Data provided by Zacks Investment Research)
Dividend History for Alexion Pharmaceuticals (NASDAQ:ALXN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Alexion Pharmaceuticals (NASDAQ:ALXN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/13/2016John B MoriartyEVPSell918$135.72$124,590.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Martin MackayEVPSell4,097$139.20$570,302.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Heidi L WagnerSVPSell53$138.65$7,348.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016David HallalCEOSell1,414$135.88$192,134.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Clare CarmichaelEVPSell1,312$138.91$182,249.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016David HallalCEOSell2,014$138.93$279,805.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Edward MillerSVPSell329$138.91$45,701.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Leonard BellDirectorSell3,995$138.92$554,985.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Vikas SinhaCFOSell1,122$138.91$155,857.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016David HallalCEOSell11,297$140.50$1,587,228.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Heidi L. WagnerSVPSell2,108$140.93$297,080.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Julie O'neillEVPSell2,858$141.83$405,350.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Leonard BellDirectorSell15,872$139.58$2,215,413.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Vikas SinhaCFOSell6,547$140.04$916,841.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Edward MillerSVPSell1,051$143.02$150,314.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2015Leonard BellDirectorSell35,000$190.66$6,673,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Leonard BellDirectorSell70,000$187.69$13,138,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Ann M VenemanDirectorSell895$187.48$167,794.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015John B. MoriartyEVPSell943$182.73$172,314.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Leonard BellDirectorSell70,000$188.20$13,174,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Saqib IslamEVPSell950$190.00$180,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015Leonard BellDirectorSell35,000$181.89$6,366,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Saqib IslamEVPSell1,558$168.44$262,429.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Leonard BellDirectorSell1,050$180.10$189,105.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Leonard BellDirectorSell27,835$179.63$5,000,001.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Leonard BellCEOSell15,952$188.07$3,000,092.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Julie O'neillEVPSell11,665$101.49$1,183,880.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Leonard BellCEOSell1,230$180.34$221,818.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Clare CarmichaelEVPSell1,490$171.15$255,013.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015David HallalCOOSell1,980$171.15$338,877.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Leonard BellCEOSell5,740$171.15$982,401.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Vikas SinhaCFOSell1,985$171.15$339,732.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Clare CarmichaelEVPSell1,665$173.75$289,293.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015David HallalCOOSell2,920$173.93$507,875.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Leonard BellCEOSell8,660$173.98$1,506,666.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Vikas SinhaCFOSell2,703$174.18$470,808.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015David HallalCOOSell1,373$174.18$239,149.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Leonard BellCEOSell5,223$174.29$910,316.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Vikas SinhaCFOSell1,571$174.19$273,652.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014David HallalCOOSell5,494$182.03$1,000,072.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Leonard BellCEOSell30,415$179.73$5,466,487.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Vikas SinhaCFOSell5,493$182.08$1,000,165.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Leonard BellCEOSell133,320$198.26$26,432,023.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Clare CarmichaelSVPSell10,000$196.25$1,962,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014William R KellerDirectorSell5,000$196.25$981,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2014Vikas SinhaCFOSell75,000$198.96$14,922,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014David HallalCOOSell30,000$190.01$5,700,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Martin MackayEVPSell9,375$191.52$1,795,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Saqib IslamSVPSell28,125$190.50$5,357,812.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Vikas SinhaCFOSell49,307$192.63$9,498,007.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014John B MoriartySVPSell10,000$189.49$1,894,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Stephen P SquintoEVPSell5,910$188.58$1,114,507.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014John B MoriartySVPSell10,000$179.00$1,790,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Stephen P SquintoEVPSell10,025$172.41$1,728,410.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Leonard BellCEOSell60,000$165.12$9,907,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2014Stephen P SquintoEVPSell76$159.50$12,122.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2014Leonard BellCEOSell44,435$160.60$7,136,261.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Leonard BellCEOSell12,199$165.38$2,017,470.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Leonard BellCEOSell197,801$165.32$32,700,461.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Leonard BellCEOSell5,912$169.17$1,000,133.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Andreas RummeltDirectorSell5,052$170.53$861,517.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Leonard BellCEOSell70,000$167.99$11,759,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Leonard BellCEOSell105,000$160.71$16,874,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Leonard BellCEOSell80,458$160.16$12,886,153.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014David HallalEVPSell1,349$158.00$213,142.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Leonard BellCEOSell5,145$157.88$812,292.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Vikas SinhaCFOSell1,525$157.82$240,675.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Leonard BellCEOSell127,289$162.93$20,739,196.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Leonard BellCEOSell1,200$164.93$197,916.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Leonard BellCEOSell105,600$162.38$17,147,328.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Leonard BellCEOSell90,280$163.60$14,769,808.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014Martin MackayEVPSell25,000$166.42$4,160,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014William R KellerDirectorSell3,425$170.00$582,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Leonard BellCEOSell70,000$166.16$11,631,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Leonard BellCEOSell70,000$155.96$10,917,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Martin MackayEVPSell3,574$160.85$574,877.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Alvin ParvenDirectorSell12,276$160.78$1,973,735.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014Leonard BellCEOSell70,000$156.20$10,934,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Stephen SquintoEVPSell7,055$158.04$1,114,972.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014David HallalEVPSell1,620$155.57$252,023.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Frank WrightSVPSell1,098$155.57$170,815.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Joseph MadriDirectorSell30,000$159.00$4,770,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Leonard BellCEOSell4,620$155.56$718,687.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Leonard BellCEOSell11,790$154.50$1,821,555.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Stephen SquintoEVPSell36,989$155.12$5,737,733.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Vikas SinhaCFOSell3,552$154.47$548,677.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2014Leonard BellCEOSell2,660$133.81$355,934.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2014Stephen SquintoEVPSell1,118$133.31$149,040.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Leonard BellCEOSell156,436$140.80$22,026,188.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Leonard BellCEOSell19,155$134.98$2,585,541.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2013Leonard BellCEOSell175,000$126.38$22,116,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Stephen P SquintoEVPSell41,037$124.06$5,091,050.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Vikas SinhaCFOSell50,000$122.97$6,148,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Joseph MadriDirectorSell30,000$115.00$3,450,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Leonard BellCEOSell3,500$115.00$402,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Stephen SquintoEVPSell1,000$114.37$114,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Leonard BellCEOSell1,850$110.07$203,629.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Leonard BellCEOSell33,150$110.19$3,652,798.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Clare CarmichaelSVPSell1,237$107.58$133,076.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Leonard BellCEOSell140,000$106.08$14,851,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Leonard BellCEOSell2,919$116.87$341,143.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Stephen P SquintoEVPSell14,125$115.33$1,629,036.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Leonard BellCEOSell212,737$114.62$24,383,914.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Stephen P SquintoEVPSell1,120$110.86$124,163.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2013David HallalEVPSell50,000$120.00$6,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Stephen P SquintoEVPSell44,125$94.97$4,190,551.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013R Douglas NorbyDirectorSell40,000$102.77$4,110,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013William R KellerDirectorSell9,770$103.00$1,006,310.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Leonard BellCEOSell31,113$105.74$3,289,888.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Leonard BellCEOSell41,220$100.85$4,157,037.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2013Leonard BellCEOSell26,700$100.24$2,676,408.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Leonard BellCEOSell11,880$96.27$1,143,687.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Stephen P SquintoEVPSell2,572$95.68$246,088.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Vikas SinhaCFOSell3,483$95.81$333,706.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2013Leonard BellCEOSell35,000$98.58$3,450,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2012Patrice CoissacSVPSell84,764$91.16$7,727,086.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Alexion Pharmaceuticals (NASDAQ:ALXN)
DateHeadline
06/28/16 07:40 AMAlexion Pharma Brexit Selloff Creates An Entry Point: Trading At 'Dark-Sky' Valuation
06/27/16 02:55 PMWhy Did Alexion’s EV-to-EBITDA Multiple Nosedive? -
06/27/16 02:55 PMWhat’s Behind Alexion’s Price-to-Earnings Premium? -
06/27/16 02:47 PMWatching Stock Sentiment for:Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - Press Telegraph
06/27/16 07:12 AMHC Stocks to watch for: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), CVS Health Corp (NYSE:CVS) - share market updates (press release)
06/27/16 06:01 AMEffects of Brexit on Pharmaceuticals and the Biotechnology Industry -
06/25/16 02:26 PMAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN): Update on Stock Performance - Press Telegraph
06/24/16 02:26 PMConsensus View on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Stock and Check on Movement - Press Telegraph
06/24/16 02:26 PMShares Dropping to a Recent Low: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - Press Telegraph
06/24/16 01:41 PM2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should -
06/24/16 12:53 PMBiotech: Buy the Brexit Blowup? -
06/24/16 09:37 AMAlexion Pharmaceuticals Inc. (ALXN) is Trading Lower on Unusual Volume for June 22 - Equities.com
06/24/16 09:26 AM10:26 am Alexion Pharma (-8%) falls to 28 month low -
06/23/16 03:54 PMAlexion Pharmaceuticals Inc. (ALXN) is Trading Higher on Unusual Volume for June 21
06/23/16 10:15 AMVolatile Movements - Flextronics International, (NASDAQ:FLEX), Alexion Pharmaceuticals, (NASDAQ:ALXN) - Hot Stocks Point
06/23/16 10:15 AMHC Stocks Outlines: Relypsa Inc (NASDAQ:RLYP), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - share market updates (press release)
06/23/16 10:15 AMTwo Movers within Analysts Observation: AbbVie Inc. (NYSE:ABBV) , Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - Street Updates
06/23/16 10:15 AMAlexion Pharmaceuticals Inc. (ALXN) is Trading Higher on Unusual Volume for June 21 - Equities.com
06/22/16 02:27 PMTop Gainers of the Day: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Biotechnology - Twin County News
06/22/16 02:27 PMAlexion Pharmaceuticals (NASDAQ:ALXN) Analyst Rating Consensus - Trade Calls
06/22/16 07:16 AMFinancial Stocks Hit Street's Expectation- Bristol-Myers Squibb (NYSE:BMY), Alexion Pharmaceuticals (NASDAQ:ALXN) - Seneca Globe
06/20/16 02:25 PMAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Yearly Sales Projections At $7093.173 - Investor Newswire
06/20/16 08:55 AMInvestor News: Investigation of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) over possible Violations of Securities Laws
06/17/16 08:30 PMSHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Alexion Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm - [Business Wire] - Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Alexion Pharmaceuticals, Inc. .
06/17/16 12:51 PMAlexion Pharmaceuticals is Now Oversold (ALXN) - Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.
06/17/16 10:22 AMActivision Blizzard Moves Up In Market Cap Rank, Passing Alexion Pharmaceuticals
06/16/16 02:26 PMAnalyst Recommended Stock: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - News Oracle
06/16/16 02:26 PMAnalyst Overview on These 2 Stocks: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Golar LNG Ltd. (NASDAQ:GLNG) - Beacon Chronicle
06/16/16 09:10 AMStock Market News for June 16, 2016 -
06/16/16 05:31 AMInvestigation for Investors in Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) over Possible Violations of Securities Laws
06/14/16 02:26 PMAnalyst Recommendation Trends: Royal Caribbean Cruises Ltd. (NYSE:RCL), Alexion Pharmaceuticals, Inc. (NASDAQ ... - Beacon Chronicle
06/14/16 07:14 AMOverview of Price Moves: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates
06/13/16 02:26 PMAlexion Pharma (ALXN): Alnylam Misstep with ALN-CC5 Does Not Make ALXN a Buy - Baird - StreetInsider.com
06/13/16 08:30 AMThe Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron -
06/11/16 02:27 PMAlexion Pharmaceuticals Inc. (ALXN) is Trading Lower on Unusual Volume for June 09 - Equities.com
06/11/16 02:27 PMWill Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Surprise This Quarter? - Investor Newswire
06/11/16 02:27 PMStock to Track: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - News Oracle
06/11/16 10:37 AMWEC Energy Group Becomes #156 Most Shorted S&P 500 Component, Replacing Alexion Pharmaceuticals
06/10/16 12:15 PM4 Stocks That Crushed the Biotechnology ETF (IBB) This Week -
06/10/16 10:50 AMComprehensive Analysis of: Amgen Inc. (NASDAQ:AMGN), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - Beacon Chronicle
06/09/16 08:19 PMAlexion Pharmaceuticals Inc. (ALXN) Fell On Disappointing Study Results - RTT News
06/09/16 08:19 PMAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Fundamental Star Rating Report - CML News
06/09/16 12:38 PMAlexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : June 9, 2016 -
06/09/16 11:18 AMAnalyst Consideration on this Stock: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - News Oracle
06/08/16 02:52 PMBiotech Stocks Lure Investment- Biogen (NASDAQ:BIIB), Alexion Pharmaceuticals (NASDAQ:ALXN) - Seneca Globe
06/08/16 02:52 PMSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals ... - PR Newswire (press release)
06/08/16 02:52 PMPerformance Overview of the company: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - News Oracle
06/08/16 01:21 PMWhat Helped Incyte Report Growth in 1Q16? -
06/08/16 10:53 AMHC Stocks Vigilant: Vascular Biogenics Ltd (NASDAQ:VBLT), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - share market updates (press release)
06/07/16 05:20 PMIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims Against Alexion Pharmaceuticals, Inc. And Advises Investors With Losses To Contact The Firm - [Business Wire] - Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Alexion Pharmaceuticals, Inc. .
About Alexion Pharmaceuticals

Alexion Pharmaceuticals logoAlexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of life-transforming therapeutic products. As of June 23, 2015, the Company had eight product candidates in clinical trials for 11 indications. The Company's product pipeline includes complement inhibitor portfolio, metabolic rare disease portfolio and preclinical candidates. Its complement inhibitor portfolio includes Soliris, ALXN1007, ALXN1210 and ALXN5500. Its metabolic rare disease portfolio includes Strensiq, Kanuma, ALXN1101 and SBC-103. The Company's preclinical candidates include mRNA Therapies, SBC-105 and other complement inhibitors. Its Soliris is approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ALXN
  • CUSIP: 01535110
Key Metrics:
  • Previous Close: $112.99
  • 50 Day Moving Average: $138.21
  • 200 Day Moving Average: $149.43
  • P/E Ratio: 169.27
  • P/E Growth: 1.10
  • Market Cap: $25.07B
  • Current Quarter EPS Consensus Estimate: $5.06 EPS
Additional Links:
Alexion Pharmaceuticals (NASDAQ:ALXN) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha